A National Resource Tools & Resources for Researchers

We offer access to a suite of advanced biomedical technologies, provide selected science and technology services, and maintain vast repositories of materials for use by the research community.

Biomedical investigators are invited to leverage Frederick National Laboratory resources and technology to meet their research goals. Learn more about the advanced biomedical technologies, technical services, and data and specimen repositories available to the research community.

Most resources listed below are available for researchers at no cost or for a nominal fee.

Partnership Development Office Director Maggie Scully engaging with attendee at AACR23

Contact the Partnership Development Office for more information at PDO@nih.gov

Scientist inserts vial into machine
At-cost services

Technical Services Program

The Frederick National Laboratory is home to scientific expertise and technological capabilities available nowhere else. Through the Technical Services Program, external investigators can access these unique capabilities and services at cost.

Datasets & Computational Tools

Access datasets, code repositories, computational tools, and more, developed by our investigators and collaborators.

Clinical Trials Reporting Program

Comprehensive database on all interventional NCI-funded clinical trials to help identify gaps and duplicate studies in clinical research, facilitate clinical trial prioritization, and standardize trial data capture and sharing.

Clinical Trials Reporting Program

SIV/SHIV Barcode Analysis Tool

An R-script with associated support files to demultiplex next-generation sequencing and determine the abundance of individually barcoded SIV/SHIV viral lineages.

Download the files

MHL Immunohistochemistry Database

The Molecular Histopathology Laboratory created this database to provide the specifics of hundreds of chromogenic and fluorescent immunohistochemical assays culled from decades of prior service requests. The database shows recommended methods including validated control tissue(s) for targeted antibodies.

View the database

DAVID: Database for Annotation, Visualization, and Integrated Discovery

DAVID provides a comprehensive set of functional annotation tools to help understand the biological meaning behind large gene lists. Powered by the DAVID Knowledgebase, it integrates multiple sources of functional annotations. The database provides several analytical tools including functional annotations, gene ID conversion, ortholog tool, gene classification, and batch gene name translations.

DAVID

CRISPR & gene-editing tools

The dbGuide is a database of validated guide RNA sequences that have been used in gene-editing experiments in human and mouse cells.

The sgRNA Scorer is a web tool that identifies putative sites and assigns a predicted activity based on our new support vector machine model.

Cancer Research Data Commons

Researchers can access cloud-based repositories with various cancer data sets. Our Center for Technical Operations Support helped develop the infrastructure enabling researchers to use a variety of analytical and visualization tools across cancer research data.

Cancer Research Data Commons

Drug Discovery

The Frederick National Laboratory provides access to technology and services for drug developers, from animal-based research to nanotechnology research and development.

HIVGenoPipe

A bioinformatics pipeline to more accurately detect HIV drug resistance and potentially improve the quality of antiretroviral therapies for people living with HIV. Scientists in our Applied and Developmental Research Directorate developed HIVGenoPipe to process genome sequence data in search of genetic variations indicative of drug resistance. This is an open-source software freely available for use by scientists and clinicians.

HIVGenoPipe

CLIA Molecular Diagnostics

High-complexity assays in niche areas not suitable for higher volume clinical testing, and access to cutting-edge technologies and specialized services.

Complex tumor spheroid models

Leverage these mechanistic studies that evaluate drug activities using a range of cell-based models. More data is available within each publication.

Compound screening

Documentation, publications, and datasets from state-of-the-art, automated and manual approaches to evaluate candidate molecules and existing therapeutics as single and combination treatments. Includes resources related to the NCI-60 Human Tumor Cell Lines Screen.

Nanotechnology

The Nanotechnology Characterization Laboratory offers multiple collaboration mechanisms, depending on researcher needs, including a free characterization program, fee-based research and development collaborations, and select fee-for-service assays.

Structural image of RAS-RAF
National Program

RAS Initiative

The RAS Initiative mobilizes the cancer research community to develop ways to treat cancers driven by the mutant RAS gene in an open model of collaboration among government, academic, and industry researchers.

Standardization concept
Related Initiative

Scientific Standards Hub

The Scientific Standards Hub strives to increase the reproducibility of data in the scientific community. By establishing and sharing standards and reference reagents for various scientific disciplines, we want to encourage the adoption of these benchmarks among researchers.

Disease-specific services

In addition to cancer research, Frederick National Laboratory investigators study HIV/AIDS and infectious diseases. They develop technologies and resources that are available to the biomedical research community.

COVID-19

Researchers can access SARS-CoV-2 serology materials, PBMCs, and serum.

HPV

Request HPV Serology materials, including the Serology Reference Standard & Proficiency Panel.

Tuberculosis

Through the Technical Service Program, FNL investigators measure levels of Mycobacterium tuberculosis DNA in nonhuman primate tissue specimens.